Skip to main content

Organigram Global Inc.

OGI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001620737

No open-market purchases or sales by Organigram Global Inc. insiders were filed in the last 90 days; 69 institutions reported holding it in 13F filings for Q2 2026, worth $7.87M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Organigram Global Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of OGI: Q2 2022 compared with Q3 2022
MeasureQ2 2022Of which not filed for Q3 2022Q3 2022Change
Holders1413120−18
Shares37.1M30.5K34.5M−2.56M (−6.9%)
Value$35.2M$27.5K$30.7M−$4.56M (−13.0%)

3 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (8)

Institutions that held Organigram Global Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to OGI in Q3 2022
InstitutionSharesValue% of portfolio
Marshall Wace, LLP43,400$38.0K0.00%
Simplex Trading, LLC18,387$16.0K0.00%
Garland Capital Management Inc10,000$9.00K0.01%
Mariner, LLC10,888$9.00K0.00%
Ameritas Advisory Services, LLC10,613$9.00K0.00%
Aquatic Capital Management LLC2,400$2.00K0.00%
Tucker Asset Management LLC62$630.00%
Axiom Investment Management LLC125$00.00%

Sold out (26)

Institutions that held Organigram Global Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Not filed for Q3 2022 yet (3)

Institutions that held Organigram Global Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding OGI in Q2 2022 that haven't filed for Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Pinnacle Private Wealth, LLC24,301$22.0K
Exane Derivatives6,000$5.48K
HC Financial Advisors Inc187$0